SEOUL, South Korea — Seegene, a world’s leading developer of multiplex molecular technologies and assays, announced that it has signed a Memorandum of Understanding (MOU) with Hamilton Company, a global leader in the design and manufacture of precision measurement devices, automated liquid handling workstations, and sample management systems. Through this strategic agreement, Seegene and Hamilton will form […]

Lexogen launches the SLAMseq product family for high throughput metabolic sequencing of RNA, developed in collaboration with the Institute of Molecular Biotechnology in Vienna, Austria.  Dr. Stefan Ameres (IMBA group leader) and Dr. Alexander Seitz (Founder and CEO of Lexogen). Vienna, Austria – Today Lexogen, the transcriptomics and next-generation sequencing company, launched the SLAMseq product family for high throughput […]

Lexogen launches the SLAMseq product family for high throughput metabolic sequencing of RNA, developed in collaboration with the Institute of Molecular Biotechnology in Vienna, Austria. Dr. Stefan Ameres (IMBA group leader) and Dr. Alexander Seitz (Founder and CEO of Lexogen). Vienna, Austria – Today Lexogen, the transcriptomics and next-generation sequencing company, launched the SLAMseq product family for high […]

Cambridge, UK OncoSpan features the largest gene coverage of any oncology reference standard Allows the most comprehensive validation of oncology gene panels and large-scale exome sequencing assays OncoSpan is supplied with free-of-charge access to online NGS validation and quality control (QC) tool, OncoMatic Cambridge, UK: Horizon Discovery (LSE: HZD) (“Horizon” or “the Company”), a global leader […]

LGC is delighted to announce that Dr Juergen Mueller has joined as Commercial and Strategic Development Director, Oligo-therapeutics. Juergen brings with him a wealth of knowledge and an extensive global network of contacts in the field of oligo-therapeutics development and manufacture.  He has a PhD in synthetic chemistry and maintains links with the University of Basel occasionally […]

LANSING, Mich. — Neogen Corporation (NASDAQ: NEOG) announced today that Richard E. Calk Jr., formerly president and chief operating officer, has resigned from the company to pursue alternative opportunities. Calk’s duties have been assumed by John Adent, who will now serve as president and chief executive officer. Adent joined the company as chief executive officer […]

New Facility Helps Scientists Advance Translational Medical Research   WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the opening of the Translational Medical Engineering Demonstration Laboratory at a ceremony on September 19.  Co-founded with the State Key Laboratory of Biochemical Engineering, this facility will serve as a center for research and […]

ST LOUIS  – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced that its leading, integrated “one space” genomics workflow and analysis solution, Clinical Genomicist Workspace (CGW), now supports clinical microarray (CMA) technology. CMA is commonly used in the constitutional setting to evaluate complex developmental disorders and is used to identify potential copy number […]

Chemistry behind Thermo Fisher Scientific’s Yfiler Plus PCR Amplification Kit helps solve decades-old cold cases SOUTH SAN FRANCISCO, Calif. — The United States Federal Bureau of Investigations (FBI) has granted approval for forensic laboratories to upload genetic profiles to the Combined DNA Index System (CODIS) database that have been generated with the Thermo Fisher Scientific Applied Biosystems Yfiler Plus […]

TUCSON, Ariz. — HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM), a provider of instruments, reagents, and services for molecular profiling applications, today announced the United States Patent and Trademark Office has issued two U.S. Patents covering HTG’s technology and applications of its technology. The first patent, U.S. Patent 9,758,829 entitled Molecular Malignancy in Melanocytic Lesions, was issued to HTG and […]